You just read:

Mallinckrodt Halts Phase 2B Trial Investigating the Use of Acthar® Gel (Repository Corticotropin Injection) in Amyotrophic Lateral Sclerosis (ALS)

News provided by

Mallinckrodt plc

Jul 16, 2019, 17:20 ET